EPIDIOLEX Trademark

Trademark Overview


On Wednesday, June 23, 2021, a trademark application was filed for EPIDIOLEX with the United States Patent and Trademark Office. The USPTO has given the EPIDIOLEX trademark a serial number of 79330764. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by GW Research Ltd. The EPIDIOLEX trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services

Medical services, veterinary services, medical analysis services; pharmaceutical services; pharmaceutical advisory services; provision of pharmaceutical information; providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid services

Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services
epidiolex

General Information


Serial Number79330764
Word MarkEPIDIOLEX
Filing DateWednesday, June 23, 2021
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6976396
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Goods and ServicesEducational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services
Goods and ServicesMedical services, veterinary services, medical analysis services; pharmaceutical services; pharmaceutical advisory services; provision of pharmaceutical information; providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid services
Goods and ServicesScientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, January 27, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 27, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 27, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGW Research Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGW Research Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, June 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 18, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 17, 2023FINAL DISPOSITION PROCESSED
Sunday, May 14, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Monday, December 12, 2022NOTIFICATION PROCESSED BY IB
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022REFUSAL PROCESSED BY IB
Friday, April 29, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 29, 2022REFUSAL PROCESSED BY MPU
Friday, April 1, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 18, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 17, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Tuesday, February 1, 2022APPLICATION FILING RECEIPT MAILED
Thursday, January 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 20, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB